SPYAL HTN-ON Med for Hypertension
-
- STATUS
- Recruiting
-
- participants needed
- 55
Summary
You are being asked to take part in a clinical research study because your blood pressure (BP) is not adequately controlled with medications. Purpose of this study is to provide more information about a medical device intended to help treat high blood pressure in patients whose blood pressure is not controlled, despite treatment with up to three blood pressure medications. The kidneys play an important role· in blood pressure control and it is believed that certain nerves in the kidney are overactive in patients with hypertension and contribute to high blood pressure. Medications alone may not be enough to control your blood pressure. Previous research has shown that disrupting the kidney nerves may decrease blood pressure.
Description
If you agree to participate in this research study, you are agreeing to undergo the screening tests, possibly have the renal denervation procedure, and return for follow-up visits for up to 3 to five years, as described in this consent. If you are initially given the renal denervation procedure, you will be followed for 36-months. If you are initially randomized to the control arm, details below, you may have the option to have it approximately 6 months after the initial procedure. After the crossover procedure, you will be followed for 36-months from that time. (Some subjects may be offered the crossover procedure as late as 36-months into the follow up time period). For those subjects, they will need to be followed for an additional 36-months if the crossover procedure occurs, which results in six years of follow up.)
FAQ
Renal Denervation Catheter ("Spyral catheter") and the Symplicity G3™ Renal Denervation Radiofrequency Generator ("generator") will be used. The generator allows the Spyral™ catheter, which is inserted into your blood vessels, to deliver low-level radiofrequency (RF) "energy" through the wall of a blood vessel to the kidney (renal artery). This will disrupt nerve activity that provides signals to the kidneys and may lower blood pressure.
Details
| Condition | blood pressure,hypertension |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | TX6050 |
| Last Modified on | 19 February 2024 |
Eligibility
How to participate?
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.